LADESSA CHRISTENSEN: Open Payments
NPI 1215367685 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 53 payments from 15 companies in 2025. Trend: 2023 $883 · 2024 $1,049 · 2025 $1,198
Food & beverage: $823Consulting: $375
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 5 | $419 |
| Novartis Pharmaceuticals Corporation | 16 | $224 |
| ABBVIE INC. | 5 | $98 |
| Organon LLC | 8 | $76 |
| Galderma Laboratories, L.P. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Incyte Corporation | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Lilly USA, LLC | 1 | $28 |
Products named: ADBRY, COSENTYX, SKYRIZI, NEMLUVIO, DUPIXENT, Sotyktu, VTAMA, OPZELURA.
Industry payments across ID — which companies pay providers there.
